Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 173 | 177 | PF00656 | 0.694 |
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.749 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.659 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.609 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.598 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.489 |
DOC_CYCLIN_yCln2_LP_2 | 149 | 155 | PF00134 | 0.438 |
DOC_MAPK_gen_1 | 74 | 84 | PF00069 | 0.456 |
DOC_PP4_FxxP_1 | 97 | 100 | PF00568 | 0.441 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.629 |
LIG_14-3-3_CanoR_1 | 128 | 133 | PF00244 | 0.585 |
LIG_14-3-3_CanoR_1 | 50 | 58 | PF00244 | 0.456 |
LIG_14-3-3_CanoR_1 | 77 | 83 | PF00244 | 0.438 |
LIG_Actin_WH2_2 | 19 | 35 | PF00022 | 0.529 |
LIG_APCC_ABBA_1 | 103 | 108 | PF00400 | 0.441 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.429 |
LIG_HP1_1 | 101 | 105 | PF01393 | 0.569 |
LIG_LIR_Apic_2 | 36 | 40 | PF02991 | 0.442 |
LIG_LIR_Apic_2 | 94 | 100 | PF02991 | 0.442 |
LIG_MYND_1 | 30 | 34 | PF01753 | 0.484 |
LIG_SH2_CRK | 153 | 157 | PF00017 | 0.425 |
LIG_SH2_CRK | 37 | 41 | PF00017 | 0.441 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.443 |
LIG_SUMO_SIM_par_1 | 80 | 87 | PF11976 | 0.445 |
LIG_WRC_WIRS_1 | 43 | 48 | PF05994 | 0.469 |
MOD_CDK_SPxxK_3 | 24 | 31 | PF00069 | 0.622 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.546 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.614 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.440 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.505 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.408 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.525 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.524 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.404 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.332 |
MOD_N-GLC_1 | 90 | 95 | PF02516 | 0.325 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.635 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.446 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.426 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.691 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.481 |
MOD_Plk_2-3 | 66 | 72 | PF00069 | 0.401 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.629 |
TRG_ER_diArg_1 | 161 | 164 | PF00400 | 0.476 |
TRG_ER_diArg_1 | 178 | 181 | PF00400 | 0.598 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.468 |
TRG_NLS_MonoExtN_4 | 125 | 131 | PF00514 | 0.591 |
TRG_Pf-PMV_PEXEL_1 | 50 | 54 | PF00026 | 0.467 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PGK0 | Leptomonas seymouri | 87% | 100% |
A0A0S4JRU2 | Bodo saltans | 62% | 100% |
A0A1X0NLE2 | Trypanosomatidae | 75% | 99% |
A0A3Q8ILV7 | Leishmania donovani | 92% | 100% |
A0A3S5IQU3 | Trypanosoma rangeli | 77% | 100% |
A4IE30 | Leishmania infantum | 92% | 100% |
D0A3V8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 88% |
E9AU54 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q0E1 | Leishmania major | 92% | 100% |
V5B3P3 | Trypanosoma cruzi | 77% | 100% |